News
Point32Health will dramatically change how and when it pays for Zepbound — the insurer’s preferred GLP-1 weight-loss drug— ...
Older men had more cardiovascular problems, like ischemic heart disease and hypertension, and had more ER and hospital stays ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results